🎙️🌟 What if you could shorten the cycle between data insights and clinical impact? Joseph Zabinski, Ph.D., M.E.M. discusses how AI removes the translational process by learning from a patient's past experience before diagnosis and picks up patterns. 📍 Watch the full episode here https://okt.to/TPWr63 📩Sign up for our email list to get notified when the next episode is released: https://okt.to/K1DCOv #AI #BehindtheInsights #Derm #RWE
关于我们
OM1 is an insights-driven technology and data company specializing in Personalized Medicine, Evidence Generation, and RWE Research powered by next-Gen A.I. platforms, regulatory-grade deep longitudinal data, and globally recognized thought leadership. Our unprecedented innovation takes RWE from Bench-to-Practice, delivering unparalleled personalized impact on the outcomes of patients and the advancement of research. We do things differently. We are pushing the boundaries of healthcare, reimagining how industry, providers, payers, and patients use real-world evidence. We are globally recognized for the integration of cutting-edge AI and data technologies. As pioneers in the field, our commitment to leveraging technology propels healthcare transformation, enhancing patient outcomes and setting new industry benchmarks.
- 网站
-
http://www.om1.com
OM1, Inc.的外部链接
- 所属行业
- 制药业
- 规模
- 51-200 人
- 总部
- Boston,Massachusetts
- 类型
- 私人持股
- 创立
- 2015
- 领域
- Health Data、Health Outcomes、Patient Reported Outcomes、Predictive Analytics、Outcomes Measurement、Outcomes Management、Value-Based Care、Real-World Evidence、Big Data和Registries
产品
地点
-
主要
31 Saint James Ave
Suite 1125
US,Massachusetts,Boston,02116
OM1, Inc.员工
动态
-
To drive meaningful impact in #drugdevelopment, researchers need scalable, high-quality data that is fit-for-purpose. Our latest blog explores how Aspen supports faster decision-making, deeper insights, and more effective evidence generation. 📖 Learn about the technology changing the research paradigm: https://okt.to/RJu9nx #Regulatory #Pharma #MedicalAffairs #ClinicalData #RealWorldEvidence #DataNetworks #OM1Aspen
-
-
🤝 Meet the OM1 team at the American Academy of Dermatology Annual Meeting! Stop by booth #2062 or schedule a time to meet and discuss how we can help power your next #dermatology breakthrough, together. 📆 Book your meeting here: https://okt.to/HrSeZR Joseph Zabinski, Ph.D., M.E.M. Catherine Richards, PhD MPH Kristine Christie David Fineza Andrew Wright
-
🫀 Our hearts belong to data this Valentine’s Day. With insights that span millions of patients, our #cardiometabolic network makes sure your research doesn’t skip a beat: ❤️ Specialized, research ready, and #regulatory grade data that fills #patientjourney gaps ❤️ Scalable solutions for tracking outcomes, care pathways, and treatment impacts ❤️ Powerful tools to accelerate your evidence generation and deliver better #patientoutcomes This Valentine’s Day, don’t just match with any data partner—choose one that truly understands your research needs. 📍 Ready to fall in love with smarter insights? Learn more: https://okt.to/jThB0R #ValentinesDay #RWD #HealthcareInnovation #RealWorldEvidence #RealWorldData #Cardiometabolic
-
OM1, Inc.转发了
Pleased to announce the first known #AI model to estimate the PHQ-9 screening and severity tool using clinical notes (ePHQ-9)!!! The model reads an existing mental health clinical encounter note from an electronic medical record and generates a score (without any effort on the part of the clinician or patient). This has the potential to greatly enhance outcomes for depressed patients in the #realworld. Thanks to OM1, Inc. for funding this amazing research. https://lnkd.in/eACRWU8i
-
💡Why settle for partial #dermatology insights when you can reveal the full #patientjourney? Access #RWD from 5,000+ providers and 780+ practices, covering conditions like #psoriasis, #atopicdermatitis, #hidradenitissuppurativa, and more. Explore whats possible 👉 https://lnkd.in/eCUKirqb
-
💡A new paradigm for #clinicaldata collection is emerging. In our latest blog, Rich Gliklich shares how this new paradigm is supported by a #regulatory compliant active data collection processes to reduce costs and increase site satisfaction. 📖 Learn more: https://okt.to/2oFOzn #RWD #RealWorldEvidence #DataNetworks #Aspen
-
-
Introducing: 🎙️🌟 Behind the Insights! A monthly video series where thought leaders and industry experts pull back the curtain to share #realworlddata, #AI, and evidence generation insights. Our first episode features Joseph Zabinski, Ph.D., M.E.M., and his thoughts on the role AI plays in #RWD for #dermatology, and how it can impact #patientoutcomes. 📍Watch the full episode here 👉 https://okt.to/u2keBT 📩 Sign up for our email list to get notified when the next episode is released: https://okt.to/kXJFvS #BehindtheInsights #Derm #RWE
-
🧠 Now Available: Full manuscript on measuring #depression outcomes in the real-world Explore how #AI transforms unstructured clinical notes from a multi-source real-world mental health database to estimate #PHQ9 scores. 📍 Read the full manuscript here: https://okt.to/7GSgXm Pedro Alves, Carl D. Marci, M.D., Chandra Cohen-Stavi, PhD, Katelynn Murray Whelan, Costas Boussios Elsevier Elsevier for Life Sciences #MentalHealth #Depression #RealWorldEvidence #RWD
-
-
❤️ This Heart Failure Awareness Week, we’re highlighting the need for better data to improve detection, treatment, and outcomes. OM1’s #HeartFailure Data Network uses #realworlddata and #AI to uncover critical insights into disease progression and care pathways. Explore the eBook to learn: 🫀 How #RWD enhances patient identification & risk stratification 🫀 #AI-driven insights for optimizing treatment 🫀 Real-world applications transforming care 📖 Read more: https://okt.to/ZvC7j1 #HFWeek2025 #HeartFailureAwareness #RealWorldEvidence
-